Christopher Fisher

1.3k total citations
30 papers, 992 citations indexed

About

Christopher Fisher is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Christopher Fisher has authored 30 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Physiology and 5 papers in Genetics. Recurrent topics in Christopher Fisher's work include Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Christopher Fisher is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Christopher Fisher collaborates with scholars based in United States, Australia and Ireland. Christopher Fisher's co-authors include Ralph N. Martins, William S. Brooks, Lirim Shemshedini, Roger Clarnette, Sam Gandy, Xiaofeng Zhou, Shaoyong Chen, Kevin Taddei, Kamil Godula and G. Anthony Broe and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Chemical Communications.

In The Last Decade

Christopher Fisher

29 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Fisher United States 18 485 388 134 116 108 30 992
Lin Zou China 19 509 1.0× 224 0.6× 96 0.7× 62 0.5× 77 0.7× 73 1.1k
Kunio Ii Japan 15 360 0.7× 201 0.5× 45 0.3× 48 0.4× 80 0.7× 38 837
Masahiro Maeda Japan 13 347 0.7× 418 1.1× 51 0.4× 114 1.0× 31 0.3× 42 995
Chiung‐Yuan Ko Taiwan 24 697 1.4× 127 0.3× 82 0.6× 58 0.5× 106 1.0× 43 1.2k
Hung Q. Nguyen United States 16 642 1.3× 125 0.3× 77 0.6× 41 0.4× 165 1.5× 25 1.4k
Tang Zhu Canada 19 603 1.2× 131 0.3× 76 0.6× 52 0.4× 251 2.3× 29 1.2k
Paul Frohna United States 17 403 0.8× 107 0.3× 318 2.4× 57 0.5× 77 0.7× 47 1.3k
Alice Zhao United States 12 642 1.3× 237 0.6× 140 1.0× 25 0.2× 27 0.3× 22 1.1k
Éric Krump Canada 15 494 1.0× 224 0.6× 59 0.4× 95 0.8× 66 0.6× 23 966
A.F. Markham United Kingdom 16 566 1.2× 69 0.2× 147 1.1× 98 0.8× 62 0.6× 35 1.0k

Countries citing papers authored by Christopher Fisher

Since Specialization
Citations

This map shows the geographic impact of Christopher Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fisher more than expected).

Fields of papers citing papers by Christopher Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fisher. The network helps show where Christopher Fisher may publish in the future.

Co-authorship network of co-authors of Christopher Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Fisher. A scholar is included among the top collaborators of Christopher Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Fisher. Christopher Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Mia L., et al.. (2017). Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells. 36(1). 45–54. 14 indexed citations
2.
Cohen, Miriam, Christopher Fisher, Mia L. Huang, et al.. (2016). Capture and characterization of influenza A virus from primary samples using glycan bead arrays. Virology. 493. 128–135. 17 indexed citations
3.
Yuan, Youxi, Jason Godfrey, Christopher Fisher, et al.. (2015). Auxin and Tryptophan Homeostasis Are Facilitated by the ISS1/VAS1 Aromatic Aminotransferase in Arabidopsis. Genetics. 201(1). 185–199. 21 indexed citations
4.
Huang, Mia L., Miriam Cohen, Christopher Fisher, et al.. (2014). Determination of receptor specificities for whole influenza viruses using multivalent glycan arrays. Chemical Communications. 51(25). 5326–5329. 54 indexed citations
5.
Thiébaut, Rodolphe, et al.. (2008). Pediatric Human Immunodeficiency Virus Infection and Circulating IgD+Memory B Cells. The Journal of Infectious Diseases. 198(4). 481–485. 23 indexed citations
6.
Sanchorawala, Vaishali, Daniel G. Wright, Karen Quillen, et al.. (2007). Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis. Bone Marrow Transplantation. 40(6). 557–562. 29 indexed citations
7.
Omwancha, Josephat, Xiaofeng Zhou, Shaoyong Chen, et al.. (2006). Makorin RING Finger Protein 1 (MKRN1) Has Negative and Positive Effects on RNA Polymerase II-Dependent Transcription. Endocrine. 29(2). 363–374. 30 indexed citations
8.
Miklossy, Judith, Kevin Taddei, Domizio Suvà, et al.. (2003). Two novel presenilin-1 mutations (Y256S and Q222H) are associated with early-onset Alzheimer’s disease. Neurobiology of Aging. 24(5). 655–662. 39 indexed citations
9.
Wardell, T. M., et al.. (2003). Late‐onset mitochondrial disorder with electromyographic evidence of myotonia. Muscle & Nerve. 28(6). 757–759. 3 indexed citations
10.
Taddei, Kevin, Christopher Fisher, Simon M. Laws, et al.. (2002). Association between presenilin-1 Glu318Gly mutation and familial Alzheimer's disease in the Australian population. Molecular Psychiatry. 7(7). 776–781. 24 indexed citations
11.
Fisher, Christopher, et al.. (2001). p53 Represses Androgen-induced Transactivation of Prostate-specific Antigen by Disrupting hAR Amino- to Carboxyl-terminal Interaction. Journal of Biological Chemistry. 276(42). 38472–38479. 90 indexed citations
12.
Bubulya, Athanasios, Shaoyong Chen, Christopher Fisher, et al.. (2001). c-Jun Potentiates the Functional Interaction between the Amino and Carboxyl Termini of the Androgen Receptor. Journal of Biological Chemistry. 276(48). 44704–44711. 41 indexed citations
13.
Bubulya, Athanasios, Xiaofeng Zhou, Xi-Qiang Shen, Christopher Fisher, & Lirim Shemshedini. (2000). c-Jun Targets Amino Terminus of Androgen Receptor in Regulating Androgen-Responsive Transcription. Endocrine. 13(1). 55–62. 20 indexed citations
14.
Laws, Simon M., Kevin Taddei, Georgia Martins, et al.. (1999). The —491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimerʼs disease. Neuroreport. 10(4). 879–882. 63 indexed citations
15.
Verdile, Giuseppe, Paul E. Fraser, John B. Kwok, et al.. (1999). Decreased secretion of amyloid precursor protein in Chinese hamster ovary cells overexpressing presenilin 1. UWA Profiles and Research Repository (University of Western Australia). 2(4). 231–239. 2 indexed citations
16.
Taddei, Kevin, Dong Won Yang, Christopher Fisher, et al.. (1998). No association of Presenilin-1 intronic polymorphism and Alzheimer's disease in Australia. Neuroscience Letters. 246(3). 178–180. 9 indexed citations
17.
18.
19.
Brooks, William S., Ralph N. Martins, Garth A. Nicholson, et al.. (1995). A mutation in codon 717 of the amyloid precursor protein gene in an Australian family with Alzheimer's disease. Neuroscience Letters. 199(3). 183–186. 25 indexed citations
20.
Fisher, Christopher, et al.. (1988). A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe and Septic Shock. Survey of Anesthesiology. 32(2). 125???127–125???127. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lin Zou Breakdown of academic impact, for papers by Kunio Ii Breakdown of academic impact, for papers by Masahiro Maeda Breakdown of academic impact, for papers by Chiung‐Yuan Ko Breakdown of academic impact, for papers by Hung Q. Nguyen Breakdown of academic impact, for papers by Tang Zhu Breakdown of academic impact, for papers by Paul Frohna Breakdown of academic impact, for papers by Alice Zhao Breakdown of academic impact, for papers by Éric Krump Breakdown of academic impact, for papers by A.F. Markham
Rankless by CCL
2026